Xenetic Biosciences, Inc. (XBIO) Financials

$3.70

$0.24 (-6.09%)
Last update: 01:00 PM EST
Day's range
$3.69
Day's range
$3.88
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20MEarning201820182019201920202020202120212022202220232023202420240%0%-20000%-20000%-40000%-40000%-60000%-60000%-80000%-80000%-100000%-100000%Profit Margin
Profit Margin
Revenue
Earnings

XBIO Income statement / Annual

Last year (2024), Xenetic Biosciences, Inc.'s total revenue was $2.50 M, a decrease of 1.56% from the previous year. In 2024, Xenetic Biosciences, Inc.'s net income was -$3.96 M. See Xenetic Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $2.50 M $2.54 M $1.71 M $1.16 M $436.94 K $17.07 K $0.00 $7.59 M $3.00 M $0.00
Cost of Revenue $0.00 $0.00 $27.04 K $35.48 K $0.00 $0.00 $15.83 K $156.12 K $36.45 K $56.12 K
Gross Profit $2.50 M $2.54 M $1.68 M $1.13 M $436.94 K $17.07 K -$15.83 K $7.43 M $2.96 M -$56.12 K
Gross Profit Ratio 1 1 0.98 0.97 1 1 0 0.98 0.99 0
Research and Development Expenses $3.29 M $3.49 M $4.77 M $3.16 M $1.73 M $4.89 M $2.88 M $4.06 M $43.74 M $3.43 M
General & Administrative Expenses $3.42 M $3.56 M $3.65 M $3.74 M $3.40 M $4.73 M $4.39 M $6.94 M $6.69 M $6.39 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $3.42 M $3.56 M $3.65 M $3.74 M $3.40 M $4.73 M $4.39 M $6.94 M $6.69 M $6.39 M
Other Expenses $0.00 $0.00 -$1.60 K $1.12 K -$492.00 $3.32 K -$24.64 K -$41.10 K $0.00 $0.00
Operating Expenses $6.70 M $7.06 M $8.42 M $6.91 M $5.13 M $9.62 M $7.28 M $11.00 M $50.43 M $9.82 M
Cost And Expenses $6.70 M $7.06 M $8.42 M $6.91 M $5.13 M $9.62 M $7.28 M $11.15 M $50.43 M $9.82 M
Interest Income $249.86 K $355.76 K $167.15 K $100.47 K $126.17 K $216.98 K $0.00 $16.54 K $32.00 $1.69 K
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $24.13 K $1.82 K $729.57 K $267.00 K
Depreciation & Amortization $0.00 -$28.21 K $27.04 K $35.48 K $28.84 K $27.49 K $15.83 K $23.78 K $36.45 K $56.12 K
EBITDA -$4.20 M -$4.52 M -$6.72 M -$5.71 M -$4.69 M -$9.58 M -$7.26 M -$3.57 M -$53.44 M -$9.77 M
EBITDA Ratio -1.68 -1.79 -3.94 -4.92 -10.74 -561.11 0 -0.47 -17.81 0
Operating Income Ratio -1.68 -1.78 -3.94 -4.95 10.41 -755.12 0 -0.47 -15.81 0
Total Other Income/Expenses Net $244.15 K $381.14 K $165.56 K $101.59 K $125.68 K $111.80 K -$24.13 K -$26.37 K -$6.78 M -$2.69 M
Income Before Tax -$3.96 M -$4.13 M -$6.55 M -$5.65 M -$13.81 M -$12.78 M -$7.30 M -$3.60 M -$54.21 M -$12.51 M
Income Before Tax Ratio -1.58 -1.63 -3.84 -4.86 -31.61 -748.57 0 -0.47 -18.07 0
Income Tax Expense $0.00 $0.00 -$165.56 K -$100.47 K -$2.92 M $3.17 M $24.13 K $26.37 K $6.05 M $2.42 M
Net Income -$3.96 M -$4.13 M -$6.39 M -$5.54 M -$10.89 M -$15.95 M -$7.30 M -$3.60 M -$54.21 M -$12.51 M
Net Income Ratio -1.58 -1.63 -3.74 -4.78 -24.93 -934.6 0 -0.47 -18.07 0
EPS -2.57 -2.71 -4.49 -5.39 -17.04 -55.92 -96.58 -49.78 -875.41 -355.34
EPS Diluted -2.57 -2.71 -4.49 -5.39 -17.04 -55.92 -96.57 -49.78 -875.41 -355.34
Weighted Average Shares Out $1.54 M $1.53 M $1.42 M $1.03 M $639.24 K $285.25 K $75.59 K $72.21 K $61.92 K $35.20 K
Weighted Average Shares Out Diluted $1.54 M $1.53 M $1.42 M $1.03 M $639.24 K $285.25 K $75.60 K $72.21 K $61.92 K $35.20 K
Link